Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...
Hosted on MSN
First-Of-Its-Kind Vagus Nerve Implant Gets FDA Approval As A Therapy For Rheumatoid Arthritis
A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment of rheumatoid arthritis. Developed by SetPoint Medical, the neuroimmune ...
(Nanowerk Spotlight) The human eye's remarkable ability to detect edges—the boundaries between light and dark areas in our visual field—is a fundamental aspect of how we perceive the world. This ...
A new technical paper titled “Hybrid tungsten oxyselenide/graphene electrodes for near-lossless 2D semiconductor phase ...
Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
Active metadevices integrated with semiconductors. (a) Hybrid silicon-metallic resonators for all-optical ultrafast active metamaterials. (b) Broadband metamaterial frequency switch with femtosecond ...
SetPoint System® is first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis SetPoint Medical, a commercial-stage medical ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, announced that it has received Breakthrough Device ...
Yokneam Illit, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (the “Company” or “Wearable Devices”), a technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback